Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1138331

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1138331

Global Body Composition Analyzers Market - 2022-2029

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Body Composition Analyzers Market is estimated to reach at a CAGR of 11.2% during the forecast period (2022-2029).

The body composition analyzer works based on bioelectrical impedance analysis (BIA). A method of measuring impedance by applying alternate electrical currents to a user, measuring their volume of water through impedance values, is known as bioelectrical impedance analysis. Body composition analysis can accurately show changes in muscle mass, body fat percentage, and fat mass.

Market Dynamics

The increasing population of obese patients and increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

In an attempt to solve some of the key social and environmental determinants of overweight and its underlying unhealthy lifestyles, countries worldwide have significantly up-scaled their policy actions. The government plays an important role in addressing lifestyle behaviors and population health, reducing health disparities and chronic disease. Government involvement includes surveillance, programming, research, quality assurance, access to health care, and guidelines for diet and physical activity(PA). Some view government as paternalistic and favor individual choice. However, there is an opportunity to unite diverse approaches with the government working across sectors and engaging the private sector. Hence, the government's initiatives to promote a healthy lifestyle will increase the awareness of the use of body composition analyzers to assess the proportion of fat to fat-free mass in the body.

The increasing population of obese patients will drive the body composition analyzers market.

According to A-Mansia Biotech, Worldwide prevalence of obesity the worldwide prevalence of obesity nearly tripled between 1975 and 2020. In fact, in 2020, more than 2 billion adults (39% of the global adult population) were overweight (BMI > 25). Of these, over 600 million were obese (BMI > 30). In Europe, more than half the population is overweight (BMI > 25), and up to 30% are obese (BMI > 30). Moreover, the World Obesity Atlas 2022, published by the World Obesity Federation, expects that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030. The most frequently used measure of obesity is body weight. In general, people with high body weights have higher amounts of body fat. Weight changes correspond to body water, fat, and lean tissue changes. Body composition is a method in which the body is divided into its core components: fat, minerals, protein, and body water. It describes weight more accurately and provides a better look into overall health than traditional methods. Body composition analysis can show real changes in fat mass, muscle mass, and body fat percentage. There are many benefits of doing a BCA now that it has surpassed the outdated Body Mass Index (BMI). There is more to being healthy than losing weight. There are important factors like increasing physical activity and improving the muscle-to-fat ratio. Thus, from the above statements, the market is expected to drive in the forecast period.

Disadvantages related to body composition analyzers will hamper its market.

Although modern technologies and assessment have helped evolve body fat analysis, there are still certain shortcomings, especially depending on the chosen method. The limitation of the method of body fat analysis is that it considers only a few areas that give room for substantial errors. This shortcoming can be avoided if the same area is used repeatedly to check the increase or decrease in body fat over time. Bioelectrical impedance is not very accurate as it works fast, which compels a compromise on accuracy, which makes the concept not so perfect. Other than fat, hydration levels in the body would also influence the response time, food, and other factors.

Depending on where one lives, DEXA scans can be quite expensive and how many centers or Fitness Clubs & Wellness Centers are around to carry the equipment needed. This is an advanced technology, and one may not have many options in a neighborhood or town.

Industry Analysis

The body composition analyzers market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

COVID-19 pandemic is expected to have a fairly positive impact on the market. As suggested by some studies, the risk of contraction of COVID-19 is more in obese patients. Additionally, with lockdown and staying at home, people have become more sedentary than before. Hence, this will drive the body composition analyzers market.

Segment Analysis

The Bio-impedance analyzer segment is expected to hold the largest market share in the body composition analyzers market.

The bio-impedance analyzer segment accounted for the largest share in 2021. It is a method of assessing body composition known as Bioimpedance Analysis (BIA). It is the measurement of body fat in relation to lean body mass. One integral part of a health and nutrition assessment is BIA. It also provides a measurement of fluid and body mass that can be a critical assessment tool for the current state of health. This non-invasive test involves the placement of two electrodes on the right hand and foot of a person. An imperceptible low-level electrical current is sent through the body, and the amount of water in the body will affect the current flow. The device measures how this signal is delayed through different types of tissue. Tissues that contain large amounts of fluid and electrolytes, such as blood, have high conductivity, but fat and bone slow the signal down. The resistance to the flow of the current passing through the body is determined by BIA, which estimates body water from which body fat is calculated using selected equations. For instance, bodivis BCA-2A records key body composition indexes accurately and shows changes like muscle mass, protein, body water and body fat percentage. This can help by validating patient care, corporate wellness and personal training. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

The hospital's segment is expected to hold the largest market share in the body composition analyzers market.

Hospitals with their large scale, strong financial capabilities, and broad range of services will see an increase in this segment. To provide a long-term solution for the treatment of obese individuals, the procedures must be simple and safe to perform, with the device's efficacy maintained throughout long treatment durations. This non-invasive technique involves the placement of electrodes on the feet, hands, or both of a person. An electrical current of low-level is sent through the body, and the current flow is affected by the amount of body water. BIA device measures this signal impeded through different tissue types (muscle has high conductivity, but fat slows the signal down). To reduce the risk of these devices, it's better to use them in a hospital setting. Hospitals provide the best medical practitioner and advanced medical devices. Hence, this segment will dominate the market.

Geographical Analysis

North American region is expected to hold the largest market share in the global body composition analyzers market.

The North American region accounted for the largest market share in 2021. The region's growth is attributed to the increasing prevalence of obesity, and rising product launches by the market players are some factors expected to boost the region in the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), the proportion of US children, who are overweight or obese, which has climbed steadily for years, surged to unprecedented levels during the pandemic. Among a cohort of 432 302 people aged 2-19 years, the body mass index (BMI) increase roughly doubled during the pandemic compared with the preceding period. The greatest increases were seen in children aged 6-11 and those already overweight before the pandemic.

Moreover, the Centers for Disease Control and Prevention reported that the number of states in which at least 35% of residents self-report obesity increased in 2020 from 12 to 16 and therefore, the US is the world's most overweight large country, with an average BMI of 26.6 in men and 26.5 in women. Therefore, it has increased the demand for body composition analyzers. Additionally, at CES Las Vegas in January 2020, Inbody USA will formally debut the InBody 970. The InBody 970, when used in conjunction with the Yscope, analyses and categorizes abdominal fat and total body water using new patented technology. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the body composition analyzers market are Bodystat, Cosmed S.R.L, GE Healthcare Inc., Hologic Inc., Inbody Co. Ltd, Jawon Medical Co. Ltd, Maltron International Ltd, Omron Healthcare Inc., Seca GmbH & Co. Kg., and Tanita Corporation, Zhengzhou YKinspection Enterprise Co., Ltd., Chongqing Xishan Science & Technology Co., Ltd, Guangzhou Lety Medical Limited.

InBody Co Ltd:

Overview:

InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.

Product Portfolio:

InBody 270: The portable and precise InBody 270 body composition analyzer provides accurate analysis for professionals on the go. Delivers standard measurements like Percent Body Fat, Skeletal Muscle Mass, BMR, and more.

The global body composition analyzers market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Product Code: DMMD1468

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market Snippet By End User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing population of obese patients will drive the body composition analyzers market
      • 4.1.1.2. Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market
    • 4.1.2. Restraints:
      • 4.1.2.1. Disadvantages related to body composition analyzers will hamper its market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Bio-impedance Analyzer *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Dual Energy X-ray Absorptiometry Equipment
  • 7.4. Skinfold Calipers
  • 7.5. Air Displacement Plethysmography Equipment
  • 7.6. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 8.1.2. Market Attractiveness Index, By End User Segment
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Fitness Clubs & Wellness Centers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Company Profiles

  • 11.1. GE Healthcare Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Bodystat
  • 11.3. Cosmed S.R.L
  • 11.4. Hologic Inc.
  • 11.5. Inbody Co. Ltd
  • 11.6. Jawon Medical Co. Ltd
  • 11.7. Maltron International Ltd
  • 11.8. Zhengzhou YKinspection Enterprise Co., Ltd.
  • 11.9. Chongqing Xishan Science & Technology Co., Ltd
  • 11.10. Guangzhou Lety Medical Limited(*LIST NOT EXHAUSTIVE)

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!